Tumor bulk-RNA seq identifies patients at high risk of progression in non-complete pathological responders
Researchers from Spain have identified an immune expression signature in surgical specimens associated with disease progression for non-complete pathological responders patients treated with neo adjuvant chemo-immunotherapy, ...
Aug 8, 2022
0
17